Réaction #1833219
ord-57d540e011964362ae5e4b8522152bf3
Équation de réaction
Réactifs
Réactifs
Conditions de réaction
Traitement
- 1workup.STIRRINGthe mixture was stirred for 2 h at −75° C
- 2workup.STIRRINGstirring
- 3workup.WAITwas continued for 1.5 h
- 4LavageThe ether phase was washed with saturated NaCl (10 mL)
- 5Séchagedried (Na2SO4)
- 6Autreevaporated under vacuum
- 7AutreThe residue was purified by chromatography on silica with hexane
- 8Autrerepurified by reverse-phase
Mode opératoire
2,2,6,6-Tetramethylpiperidine (2.1 mL, 1.8 g, 12 mmol) was dissolved in dry tetrahydrofuran (15 mL), cooled to −75° C. and treated with n-butyllithium (n-BuLi, 2.5 M; 4.8 mL, 12 mmol), and the mixture was stirred for 30 min at −75° C. 5-Bromo-2,2-difluorobenzo[d][1,3]dioxole (2.0 g, 8.4 mmol) was added, and the mixture was stirred for 2 h at −75° C. 1,1,2-Trichloro-1,2,2-trifluoroethane (2.4 mL, 3.8 g, 20 mmol) was added and stirring was continued for 1.5 h. Saturated NH4Cl (10 mL) was added, and the mixture was shaken with diethyl ether (30 mL) and water (20 mL). The ether phase was washed with saturated NaCl (10 mL), dried (Na2SO4) and evaporated under vacuum. The residue was purified by chromatography on silica with hexane and then repurified by reverse-phase HPLC using 75% acetonitrile to give the title compound as a clear liquid (640 mg, 28%): 1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J=8.5, 5.1 Hz, 1H), 6.90 (dd, J=9.0, 4.7 Hz, 1H); EIMS m/z 332.